ANTAGONISM OF LEUKOTRIENE RESPONSES IN HUMAN AIRWAYS BY BAY X7195

被引:7
作者
GORENNE, I
ORTIZ, JL
LABAT, C
ABRAM, T
TUDHOP, S
CUTHBERT, N
NORMAN, P
GARDINER, P
MORCILLO, E
BRINK, C
机构
[1] CTR CHIRURG MARIE LANNELONGUE,CNRS,URA 1159,F-92350 LE PLESSIS ROBINS,FRANCE
[2] BAYER PLC,RES DEPT,PHARMACEUT BUSINESS GRP,STOKE POGES SL2 4LY,BUCKS,ENGLAND
[3] UNIV VALENCIA,DEPT FARMACOL,E-46100 VALENCIA,SPAIN
关键词
AIRWAY HUMAN; LEUKOTRIENE; ANTIIMMUNOGLOBULIN E; CONTRACTION; CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST;
D O I
10.1016/0014-2999(94)00777-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Contractions induced by leukotriene and anti-IgE (sheep antiserum to human IgE) were antagonized by pretreatment of human airways with the cysteinyl leukotriene receptor antagonist BAY x7195 ((4S)-[4-carboxyphenylthio]-7-[4-(4-phenoxybutoxy)-phenyl]-hept-5-(z)-enoic acid). However, this receptor antagonist did not inhibit either leukotriene D-4- or leukotriene C-4-induced contractions in human pulmonary veins. The pA(2) value for BAY x7195 in human airways against leukotriene D-4 was 7.83 +/- 0.16 with a slope of 1.07 +/- 0.15 (means +/- S.E.M; n = 11). The IC50 value for BAY x7195 in human airways contracted with anti-IgE was 0.31 +/- 0.08 mu M (n = 11). These results were comparable to those obtained with ICI 204,219 (4-(5-cyclopentyl-oxycarbonylamino-1-methylindol-3-ylmethyl)-3-methoxy-N-otolyl-sulfonylbenzamide). These data demonstrate that BAY x7195 is a potent selective leukotriene receptor antagonist which may block allergic reactions in the lung.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 22 条
[1]   THE EFFECT OF AN ORAL LEUKOTRIENE ANTAGONIST L-649,923 ON HISTAMINE AND LEUKOTRIENE-D4-INDUCED BRONCHOCONSTRICTION IN NORMAL MAN [J].
BARNES, N ;
PIPER, PJ ;
COSTELLO, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (05) :816-821
[2]   LEUKOTRIENES AND HISTAMINE MEDIATE IGE-DEPENDENT CONTRACTIONS OF HUMAN BRONCHI - PHARMACOLOGICAL EVIDENCE OBTAINED WITH TISSUES FROM ASTHMATIC AND NONASTHMATIC SUBJECTS [J].
BJORCK, T ;
DAHLEN, SE .
PULMONARY PHARMACOLOGY, 1993, 6 (01) :87-96
[3]   THE EFFECT OF AN ORAL LEUKOTRIENE-D4 ANTAGONIST L-649,923 ON THE RESPONSE TO INHALED ANTIGEN IN ASTHMA [J].
BRITTON, JR ;
HANLEY, SP ;
TATTERSFIELD, AE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (05) :811-816
[4]  
BUCKNER CK, 1986, J PHARMACOL EXP THER, V237, P558
[5]   THE POTENT AND SELECTIVE SULFIDOPEPTIDE LEUKOTRIENE ANTAGONIST, SK-AND-F-104353, INHIBITS ASPIRIN-INDUCED ASTHMA [J].
CHRISTIE, PE ;
SMITH, CM ;
LEE, TH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :957-958
[6]   ALLERGEN CHALLENGE OF LUNG-TISSUE FROM ASTHMATICS ELICITS BRONCHIAL CONTRACTION THAT CORRELATES WITH THE RELEASE OF LEUKOTRIENE-C4, LEUKOTRIENE-D4, AND LEUKOTRIENE-E4 [J].
DAHLEN, SE ;
HANSSON, G ;
HEDQVIST, P ;
BJORCK, T ;
GRANSTROM, E ;
DAHLEN, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (06) :1712-1716
[7]  
DAHLEN SE, 1982, NATURE, V288, P484
[8]   EVIDENCE FOR MULTIPLE LEUKOTRIENE-D4 RECEPTORS IN SMOOTH-MUSCLE [J].
FLEISCH, JH ;
RINKEMA, LE ;
BAKER, SR .
LIFE SCIENCES, 1982, 31 (06) :577-581
[9]   LEUKOTRIENE-B, A POTENT CHEMOKINETIC AND AGGREGATING SUBSTANCE RELEASED FROM POLYMORPHONUCLEAR LEUKOCYTES [J].
FORDHUTCHINSON, AW ;
BRAY, MA ;
DOIG, MV ;
SHIPLEY, ME ;
SMITH, MJH .
NATURE, 1980, 286 (5770) :264-265
[10]   EFFECT OF THE ORAL LEUKOTRIENE D4 ANTAGONIST LY171883 ON INHALED AND INTRADERMAL CHALLENGE WITH ANTIGEN AND LEUKOTRIENE D4 IN ATOPIC SUBJECTS [J].
FULLER, RW ;
BLACK, PN ;
DOLLERY, CT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (05) :939-944